LOTUSEYE · Health Care · 2026-08-21

Lotus Eye Hospital and Institute Ltd

4.0WatchEven +1.2Stage 2 · wk 9In scan: Breakout WatchMARKET: BULL RISING · 2026-08-21
₹115.6
-1.29% today
₹240 Cr · Micro cap
About this companyHealth Care· Hospitals & Diagnostic Centres
Expand ▾

Lotus Eye Hospital and Institute Limited, a specialty eye care hospital, provides eye care and related services in India. The company offers ReLEx SMILE, a refractive lenticule extraction small incision lenticule extraction; touch free laser; lasik eye surgery; Epi-LASIK, an epithelial laser in situ keratomileusis; Intralase, a blade-free technique to create the corneal flap; Zyoptix Supracor laser technology; robotic femto laser cataract surgery; phacoemulsification; paediatric eye care and squint surgery; and micro incision cataract surgery treatments. It provides treatment services for various eye problems, such as refractive, cataract, glaucoma, retinal disease/diabetic eye care, neuro ophthalmology, binocular vision, and cornea infections, as well as various eye related courses. The company was formerly known as Lotus Eye Care Hospital Limited and changed its name to Lotus Eye Hospital and Institute Limited in April 2013. Lotus Eye Hospital and Institute Limited was founded in 1989 and is based in Coimbatore, India.

Visit company website →
P/E (TTM)
338.4
Forward —
vs 52W High
-18.2%
₹75.7 lo₹141.4 hi
18.2% below 52W high — deeper pullback
How far this stock is from its 52-week high. A pullback of 3–20% while Stage 2 structure holds is typically a better entry than chasing near the high.
Stage Maturity
Week 9
1w13w26w
Week 9 — early Stage 2, building
How long this stock has been in Stage 2. The sweet spot is typically 13–26 weeks — enough time to prove the structure holds, not so long it's extended. Very fresh (wk 1–4) often needs more time to confirm.
vs 200 DMA
-0.6%
200 DMA: ₹116.3 · sloping down
Long-term trend anchor. When stock and Nifty are both above their 200 DMA, the macro backdrop supports continuation.
Rel Volume
0.24x
vs 50-day avg
Low vol (0.5–1x) on pullbacks = resting, not being sold. High vol on breakouts = commitment. Volume spike on down days is a warning sign.
Trend Health
↓
MA20 rolling over · -2.0% vs MA50 +1.6%
Two-layer momentum read: the glyph shows whether the 20-day MA is rising (↑/↗), flat (→), or rolling over (↓). The ⇈ flag fires when the 20-day MA is pulling away from the 50-day MA — short-term momentum building on top of the longer trend. Best when both glyphs agree.
Sector
Health Care
↑ Building
Stage 2%
55.5%
20d Δ
+3.9pp
1M return
+2.7%
3M return
+9.6%
Sector Stage-2 % · last 20 days
This stock ranks #16 of 84 Stage 2 stocks in Health Care by RS.
Industry
Hospitals & Diagnostic Centres
↓ Peaking
Stage 2%
55.6%
20d Δ
-7.4pp
1M return
-2.8%
3M return
+2.0%
Industry Stage-2 % · last 20 days
Ranks #1 of 15 Stage 2 stocks in this industry. Top stock in industry.
Price + Volume Chart
Loading price chart…
Stage Cycle Timeline2023-05-26 → 2026-08-21
S2 15w
S4 23w
S3 15w
S2 15w
2023-05-262026-08-21
S1S2S3S4Setup score (0–10, dashed line at 5)
S1 4w → S2 15w → S3 6w → S2 10w → S3 2w → S4 23w → S1 8w → S2 8w → S3 15w → S4 10w → S1 4w → S2 9w → S3 2w → S2 15w → S3 5w → S2 2w → S3 3w → S2 5w → S3 8w → S4 4w → S1 2w → S2 9w current
Total tracked: 167 weeks across 22 stage runs.
1M
-2.3%
3M
+5.9%
6M
-2.6%
YTD
-9.8%
1Y
+56.7%
Scan Membership
Breakout Watch
Latest: 2026-06-22
6 appearances in last 60 days. First seen: 2024-09-13.
Stocks that stay in the scan for 13+ weeks are in the highest observed-return cohort — they keep qualifying because the structure remains intact, not by luck. Persistence in the scan is itself a quality signal.
Recent Stage Timeline
2026-08-21S2
Wk 9 · Vol —x
2026-08-20S2
Wk 9 · Vol —x
2026-08-19S2
Wk 9 · Vol —x
2026-08-18S2
Wk 9 · Vol —x
2026-08-17S2
Wk 8 · Vol —x
2026-08-14S2
Wk 8 · Vol —x
2026-08-13S2
Wk 8 · Vol —x
2026-08-12S2
Wk 8 · Vol —x
2026-08-11S2
Wk 8 · Vol —x
2026-08-10S2
Wk 7 · Vol —x
2026-08-07S2
Wk 7 · Vol —x
2026-08-06S2
Wk 7 · Vol —x
Sector Peers — Stage 2All →
NEULANDLAB
wk 12 · -1.5% from hi
9.0
ALIVUS
wk 19 · -3.4% from hi
9.0
DIVISLAB
wk 14 · -0.0% from hi
8.8
SAILIFE
wk 25 · -1.0% from hi
8.8
SHILPAMED
wk 15 · -0.9% from hi
8.6
Moving averages & range
50 DMA
₹121.7
200 DMA
₹116.3
52W High
₹141.4
52W Low
₹75.7
5D Low
₹115.5
Resistance levels (recent highs)
20d High
₹119.8
60d High
₹140
120d High
₹140
250d High
₹141.4
Next resistance
+3.6%
to 20d High

All analytics based on EOD data. Data as of 2026-08-21. Past data patterns are not indicative of future results. This page is a data analytics tool only.